Clover Health Investments, Corp CLOV
$4.49
-1.10%
at last close
Analyst Consensus
- Consensus Rating
- Hold (1 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $4.33
- Implied Upside
- -3.5%
- Price Target Range
- $2.50 – $5.50
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-06 | UBSJonathan Yong |
Maintains | Neutral | $5 → $5 |
| 2026-07-21 | Canaccord GenuityRichard Close |
Maintains | Buy | $4 → $6 |
| 2026-06-11 | UBSJonathan Yong |
Maintains | Neutral | $3 → $5 |
| 2026-06-04 | Canaccord GenuityRichard Close |
Maintains | Buy | $3 → $4 |
| 2026-03-20 | Canaccord GenuityRichard Close |
Maintains | Buy | $4 → $3 |
| 2026-03-05 | Leerink PartnersWhit Mayo |
Maintains | Market perform | $3 → $3 |
| 2026-01-20 | Canaccord GenuityRichard Close |
Maintains | Buy | $4 |
| 2025-11-06 | Canaccord GenuityRichard Close |
Maintains | Buy | $4 → $4 |
| 2025-08-07 | Canaccord GenuityRichard Close |
Maintains | Buy | $5 → $4 |
| 2025-08-06 | UBSJonathan Yong |
Maintains | Neutral | $5 → $3 |
| 2025-03-03 | Canaccord GenuityRichard Close |
Maintains | Buy | $4 → $5 |
| 2024-12-17 | Craig-HallumMatt Hewitt |
Initiates coverage on | Buy | $6 |
| 2024-10-07 | UBSJonathan Yong |
Initiates coverage on | Neutral | $4 |
| 2023-08-11 | CitigroupJason Cassorla |
Maintains | Neutral | $1 → $2 |
| 2023-03-06 | Canaccord GenuityRichard Close |
Maintains | Buy | $4 → $3 |
| 2023-03-06 | Credit SuisseJonathan Yong |
Maintains | Underperform | $3 → $1 |
| 2022-11-16 | CitigroupJason Cassorla |
Maintains | Neutral | $4 → $2 |
| 2022-11-08 | SVB LeerinkWhit Mayo |
Maintains | Market perform | $3 → $2 |
| 2022-08-09 | CitigroupJason Cassorla |
Maintains | Neutral | $3 → $4 |
| 2022-08-09 | Credit SuisseJonathan Yong |
Maintains | Underperform | $4 → $3 |
| 2022-05-10 | SVB LeerinkWhit Mayo |
Maintains | Market perform | $3 → $3 |
| 2022-02-25 | SVB LeerinkWhit Mayo |
Maintains | Market perform | $3 → $3 |
| 2022-02-02 | Canaccord GenuityRichard Close |
Initiates coverage on | Buy | $6 |
| 2022-02-02 | Cowen & Co.Gary Taylor |
Upgrades | Underperform → Market perform | $7 → $3 |
| 2022-01-19 | SVB LeerinkWhit Mayo |
Initiates coverage on | Market perform | $3 |
| 2022-01-07 | Credit SuisseJonathan Yon |
Downgrades | Neutral → Underperform | $9 → $4 |
| 2021-11-15 | Credit SuisseJonathan Yon |
Maintains | Neutral | $8 → $9 |
| 2021-09-10 | Cowen & Co.Gary Taylor |
Initiates coverage on | Underperform | $7 |
| 2021-07-12 | JP MorganGary Taylor |
Downgrades | Neutral → Underweight | $9 |
| 2021-06-10 | B of A SecuritiesKevin Fischbeck |
Downgrades | Neutral → Underperform | $10 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.49
- Market Cap
- $2.41 billion
- 52-Week Range
- $1.58 – $5.59
- Average Volume
- 4.94 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.